These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7432436)
21. Editorial: Relationship of stilbestrol exposure in utero to vaginal lesions in adolescence. Carrington ER J Pediatr; 1974 Aug; 85(2):295-6. PubMed ID: 4841967 [No Abstract] [Full Text] [Related]
22. NCI pamphlet discusses effects of DES exposure in utero. Am Fam Physician; 1977 Sep; 16(3):271-2. PubMed ID: 900005 [No Abstract] [Full Text] [Related]
23. Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. Taft PD; Robboy SJ; Herbst AL; Scully RE Acta Cytol; 1974; 18(4):279-90. PubMed ID: 4526247 [No Abstract] [Full Text] [Related]
25. Clear cell adenocarcinoma in young females. Hertrich O Obstet Gynecol; 1973 Apr; 41(4):494-500. PubMed ID: 4696964 [No Abstract] [Full Text] [Related]
26. Health risks and effects of prenatal exposure to diethylstilbestrol. Johnston GA J Fam Pract; 1983 Jan; 16(1):51-4. PubMed ID: 6848637 [TBL] [Abstract][Full Text] [Related]
27. Clear cell (mesonephric) adenocarcinoma of the vagina. A case report. Rosati LA; Jarzynski DJ Acta Cytol; 1973; 17(6):493-7. PubMed ID: 4127770 [No Abstract] [Full Text] [Related]
28. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. Scully RE; Robboy SJ; Herbst AL Ann Clin Lab Sci; 1974; 4(4):222-33. PubMed ID: 4460850 [TBL] [Abstract][Full Text] [Related]
29. Vaginal cancer after maternal treatment with synthetic estrogens. Greenwald P; Barlow JJ; Nasca PC; Burnett WS N Engl J Med; 1971 Aug; 285(7):390-2. PubMed ID: 5556578 [No Abstract] [Full Text] [Related]
30. Microglandular hyperplasia in vaginal adenosis associated with oral contraceptives and prenatal diethylstilbestrol exposure. Robboy SJ; Welch WR Obstet Gynecol; 1977 Apr; 49(4):430-4. PubMed ID: 857207 [TBL] [Abstract][Full Text] [Related]
31. In utero exposure to DES: what have we learned? Noller KL Mayo Clin Proc; 1981 Sep; 56(9):577-8. PubMed ID: 7266070 [No Abstract] [Full Text] [Related]
32. Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina. Sperling MA West J Med; 1975 Jan; 122(1):42-9. PubMed ID: 1089006 [No Abstract] [Full Text] [Related]
33. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina. Hill EC Trans Pac Coast Obstet Gynecol Soc; 1972; 40():15-29. PubMed ID: 4668177 [No Abstract] [Full Text] [Related]
34. Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy. Barber HR; Sommers SC Obstet Gynecol; 1974 May; 43(5):645-52. PubMed ID: 4822648 [No Abstract] [Full Text] [Related]
35. [Synthetic estrogen and vaginal adenocarcinoma]. Nir I Harefuah; 1972 Aug; 83(3):127. PubMed ID: 4640480 [No Abstract] [Full Text] [Related]
36. [The stilbestrol--adenosis--carcinoma--syndrome. A review]. Ulfelder H Geburtshilfe Frauenheilkd; 1975 May; 35(5):329-33. PubMed ID: 1150064 [No Abstract] [Full Text] [Related]
38. The effects in the human of diethylstilbestrol (DES) use during pregnancy. Herbst AL Princess Takamatsu Symp; 1987; 18():67-75. PubMed ID: 3506546 [TBL] [Abstract][Full Text] [Related]
39. Diethylstilbestrol exposure: how well informed are you about this health risk? Schulmeister L Clin J Oncol Nurs; 2003; 7(4):373-4. PubMed ID: 12929266 [No Abstract] [Full Text] [Related]
40. [Exposure to diethylstilbestrol during pregnancy as a cause for developmental abnormalities of the genitalia]. Santti R; Mäkelä S; Pylkkänen L Duodecim; 1990; 106(18):1242-8. PubMed ID: 1670552 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]